- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01317394
Study and Analysis of Micafungin for Non-albican Candidemia: Efficacy, Risk Factor and Clinical Manifestation
March 16, 2011 updated by: Taipei Medical University WanFang Hospital
Retrospective Study and Analysis of Micafungin for Non-albican Candidemia: Efficacy, Risk Factor and Clinical Manifestation
This study is a retrospective research in order to compare and analysis the risk factor, clinical manifestation and efficacy of albicans candidemia by pulling medical records.
We hope that this retrospective research will let us understand the method of treatment and prevention of albicans candidemia in order to improve the quality of healthcare.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan
- Taipei Medical University - WanFang Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
non-albicans candidemia patients
Description
Inclusion Criteria:
- above 20 years old
- hospital patients
- albicans candidemia patients
Exclusion Criteria:
- pregnant patients or patients under 16 years old
- liver cirrhosis and Child C
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Wen-Sen Lee, Taipei Medical University WanFang Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2010
Study Completion (Actual)
February 1, 2011
Study Registration Dates
First Submitted
March 15, 2011
First Submitted That Met QC Criteria
March 16, 2011
First Posted (Estimate)
March 17, 2011
Study Record Updates
Last Update Posted (Estimate)
March 17, 2011
Last Update Submitted That Met QC Criteria
March 16, 2011
Last Verified
March 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 99078
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Non-albicans Candidemia
-
Cairo UniversityUnknown
-
University of PittsburghPfizerCompletedInfection | Candida | Non Albicans SpeciesUnited States
-
Taipei Medical University WanFang HospitalUnknownCandidemia Prognostic Factor and Mycobiological Analysis.Taiwan
-
Fujian Shengdi Pharmaceutical Co., Ltd.Not yet recruitingPatients With Candidemia and/or Invasive Candidiasis
-
Centre Hospitalier Universitaire DijonUnknown
-
Karolinska University HospitalCompletedThe Value of Procalcitonin in Patients With Suspected CandidemiaSweden
-
King Saud UniversityActive, not recruitingCigarette Smoking | Candida Albicans InfectionSaudi Arabia
-
Hams Hamed AbdelrahmanActive, not recruiting
-
CanXidaCitruslabsActive, not recruitingCandida Infection | Candida Albicans Infection | Candida SystemicUnited States
-
Radboud University Medical CenterHorizon 2020 - European CommissionRecruitingCandidemiaNetherlands, United States, Switzerland, Germany, Romania, Greece